A Study Evaluating the Perception of Insertion Pain With Accu-Chek FlexLink and FlexLink Plus Insulin Pump Devices Under Real Life Conditions in Diabetic Patients.

Inclusion criteria

• Male and female subjects at least 18 years of age
• Diabetes mellitus type 1 or type 2
• Continuous subcutaneous insulin therapy (CSII) for at least 3 months
• Insulin pump compatible with Luer lock infusion set (Accu-Chek, Disetronic, Animas, Deltec Cozmo and Minimed 506 to 508)
• Sufficient potential infusion sites suitable for the usage of a cannula length of 8 mm and a tubing length of 70 and 80 cm
• Willing to measure blood glucose at least 4 times per day and 1-3 hrs after each new insertion
• Willing and able to participate and comply with study procedures including the general recommendation of shifting infusion sets (at least every 3 days)

Exclusion criteria

• Significantly impaired awareness of hypoglycemia
• A history of or high risk of ketoacidosis during CSII therapy
• Frequent catheter abscesses in the past year, as per investigator´s discretion
• Known strong plaster incompatibility and/or allergy (history of catheter use)
• Unstable chronic disease other than diabetes
• Chronic use of steroids in adrenal suppressive doses, other immuno-modulatory medication or chemotherapy
• Acute illness or abnormality at the time of screening rendering the patient not suitable to participate in the study in the opinion of the Investigator
• Chronic use of analgesics and any other condition interfering with the assessment of pain, as per investigator´s discretion
• Are either pregnant or breastfeeding or are currently planning a pregnancy